Fibroblastic sleeve and short peripheral catheter failures: Impact of risk factors
The Journal of Vascular Access · 2026
DOI: 10.1177/11297298251395371 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Alessia Meschia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Catheterization, Peripheral, Catheters, Indwelling, Equipment Failure, Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Short peripheral catheters (SPC) are commonly used in hospitalized patients to provide vascular access for short-term intravenous therapies. However, complications such as infection, thrombophlebitis, and fibroblastic sleeve formation can lead to premature catheter failure, negatively impacting patient care and increasing healthcare costs.
Objective
This study aims to identify risk factors associated with fibroblastic sleeve formation and evaluate their role in SPC failure, thereby supporting improved risk stratification and catheter management.
Methods
This is a secondary analysis of a prospective observational study involving 200 devices, monitored daily with ultrasound to detect complications, including fibroblastic sleeves. Patient-related and therapy-related risk factors were analyzed using univariate and multivariate Cox models to identify predictors of fibroblastic sleeve formation and device failure.
Results
Of the 200 catheters, 94 (47%) developed fibroblastic sleeves detectable by ultrasound. In multivariate analysis, antibiotic therapy requiring central venous access was the only independent predictor of its formation ( p = 0.03; HR, 2.09; 95% CI, 1.08–4.03). Risk factors independently associated with failure included older age, diabetes, cancer, bedridden status, use of antibiotics requiring central access, and omeprazole infusion.
Conclusions
Antibiotic infusion through short peripheral catheters was identified as a key risk factor for fibroblastic sleeve formation, while patient-related factors and specific therapies were associated with catheter failure. These findings underscore the importance of selecting and monitoring devices carefully in high-risk patients to minimize complications and enhance vascular access outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy.
- Post Anesthesia Care Unit, Vascular Access Team ASST Lodi, Lodi, Italy.
- University of Milan, ASST Fatebenefratelli Sacco Section, Luigi Sacco Hospital, Milan, Italy.
- Auxologico San Luca, Reparto Cardiologico acuti Riabilitazione, Milan, Italy.
ORCID-Profile: Davide Giustivi, Antonio Gidaro
Zitieren
APA
Meschia, A., Giustivi, D., Celano, R., Cattalani, M., Camilli, C., Bartoli, A., Urso, F., Calloni, M., Cirigliano, F., Taino, A., Cogliati, C., & Gidaro, A. (2026). Fibroblastic sleeve and short peripheral catheter failures: Impact of risk factors. The Journal of Vascular Access. https://doi.org/10.1177/11297298251395371
Vancouver
Meschia A, Giustivi D, Celano R, Cattalani M, Camilli C, Bartoli A, et al. Fibroblastic sleeve and short peripheral catheter failures: Impact of risk factors. The Journal of Vascular Access. 2026. doi:10.1177/11297298251395371
BibTeX
@article{Meschia2026,
author = {Meschia, Alessia and Giustivi, Davide and Celano, Rosita and Cattalani, Manuela and Camilli, Claudia and Bartoli, Arianna and Urso, Francesco and Calloni, Maria and Cirigliano, Federica and Taino, Alba and Cogliati, Chiara and Gidaro, Antonio},
title = {Fibroblastic sleeve and short peripheral catheter failures: Impact of risk factors},
journal = {The Journal of Vascular Access},
year = {2026},
doi = {10.1177/11297298251395371}
}
EUVIMED